뒤로
NovaBay Pharmaceuticals Inc(NBY) 가격
NBY 주가 차트
NBY 수입
NovaBay Pharmaceuticals Inc
$14.77
16.39%
$2.08
종가: Jan 16, 16:00:00 GMT-5
$12.91
-12.59%
$-1.85
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$12.69
시가
$12.3
일일 범위
$11.91 - $18.4
52주 범위
$0.46 - $19.95
거래량
2.7M
평균 거래량
1.2M
EPS(TTM)
-6.62
배당수익률
--
시가총액
$1.6B
NBY란 무엇인가요?
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.